Lotus Eye Hospital & Institute Ltd share price logo

Lotus Eye Hospital & Institute Ltd (LOTUSEYE)

₹70.434.17%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹65.03
    ₹72.4
  • 52 Week's Low

    52 Week's High

    ₹48.5
    ₹111
1 Month Return+ 9.49 %
3 Month Return+ 13.53 %
1 Year Return-27.57 %
Previous Close₹67.61
Open₹67.55
Volume7.04L
Upper Circuit-
Lower Circuit-
Market Cap₹140.63Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹140.63 Cr
P/B Ratio2.1
EPS0

Company Information

Lotus Eye Care Hospital is a state-of-the-art, superspecialty eye care hospital group operating in South India. Established in 1997, the hospital has three main operating centers in Coimbatore, Salem, and Tirupur. It is fitted with 9 operation theaters, 3 Lasik laser equipments, and has a total of 120 beds exclusive of the beds used in eye camps. In the year 1998, Lotus became the first hospital in South East Asia to introduce Multi Scan Lasik and in 2002, wave front based Esiris Custom Lasik in India for the first time. Moreover, in July 2004, Lotus was the first hospital to introduce Epilasik, and Zyoptix Integrated Epilasik in June 2005. In 2006-2007, Dr S K Sundaramoorthy, promoter of the company merged his business Dr. S. K. S. Eye Care Centre Pvt. Ltd. to the company. With its modern setup, hitech eye care equipment, and ophthalmic experts, Lotus Eye Care Hospital is dedicated to providing the best of eye care services in the region.

Share Price: ₹70.43 per share as on 15 Jul, 2024 04:01 PM
Market Capitalisation: ₹140.63Cr as of today
Listing date: 11 Jul, 2008
Chairperson Name: Kaveetha Sundaramoorthy
OrganisationLotus Eye Hospital & Institute Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Lotus Eye Hospital & Institute Ltd

  • Lotus Eye Hospital & Institute VP Sells 92% of Holding - 15 Mar, 2024

    Vice President of Administration, Rajkumar Sundaramoorthy, sold 92% of their holding in Lotus Eye Hospital and Institute for ₹173m. This is the biggest sale made by an insider individual in the last twelve months. While insider selling is not a positive sign, it's only a weak signal that insiders think shares are fully valued.

  • Lotus Eye-care Hospital and Institute Touches 52-Week Low - 05 Mar, 2024

    High-frequency trading firms have been active in small, illiquid stocks like Lotus Eye-care Hospital and Institute, which touched a 52-week low.

Insights on Lotus Eye Hospital & Institute Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 58.60% to 59.75% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LOTUSEYE stock has moved up by 17.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 238.2% return, outperforming this stock by 202.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Global Health Ltd has given 71.5% return, outperforming this stock by 99.1%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 41.40% to 40.24% in Jun 2024 quarter

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹63.19Cr
↑2.58%
Total Liabilities
₹5.61Cr
↓19.74%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹4.39Cr
↓0.45%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
40.24%
-2.79
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
59.75%
1.96
Others
0.01%
0.00

Key Indicators

Earnings and Dividends

  • Lotus Eye Hospital & Institute Ltd Earnings Results

    Lotus Eye Hospital & Institute Ltd’s net profit fell -96.92% since last year same period to ₹0.02Cr in the Q4 2023-2024. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated -96.97% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Lotus Eye Hospital & Institute Ltd Dividends May,2023

    In the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.48%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Lotus Eye Hospital & Institute Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Lotus Eye Hospital & Institute Ltd shares.

Lotus Eye Hospital & Institute Ltd (LOTUSEYE) share price today is ₹70.43

Lotus Eye Hospital & Institute Ltd is listed on NSE

Lotus Eye Hospital & Institute Ltd is listed on BSE

  • Today’s highest price of Lotus Eye Hospital & Institute Ltd is ₹72.4.
  • Today’s lowest price of Lotus Eye Hospital & Institute Ltd is ₹65.03.

Today’s traded volume of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is 7.04L.

Today’s market capitalisation of Lotus Eye Hospital & Institute Ltd(LOTUSEYE) is ₹140.63Cr.

Lotus Eye Hospital & Institute Ltd(LOTUSEYEPrice
52 Week High
₹111
52 Week Low
₹48.5

Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹70.43. It is down -36.55% from its 52 Week High price of ₹111

Lotus Eye Hospital & Institute Ltd(LOTUSEYE) share price is ₹70.43. It is up 45.22% from its 52 Week Low price of ₹48.5

Lotus Eye Hospital & Institute Ltd(LOTUSEYEReturns
1 Day Returns
2.82%
1 Month Returns
9.49%
3 Month Returns
13.53%
1 Year Returns
-27.57%